Immunorestoration in children with recurrent respiratory infections treated with isoprinosine

Abstract

In 27 children, 4–8 years old, with recurrent respiratory infections of the upper and lower respiratory tracts Isoprinosine®(ISO) tablets were administered for 7 – 10 days at daily doses of 50–100 mg/ kg. Clinical signs of acute respiratory disease, including temperature abnormalities and subjective complaints, subsided in a short time and the children showed no symptoms for periods ranging from several weeks to several months following the theraphy. The children were selected for immunotherapy wit ISO on the basis of their low levels of E-rosette forming cells in peripheral blood. Several immune function parameters assessed immediately after treatment with ISO and compared with those obtained before illness and ISO administration. Low levels of T-lymphocytes returned to normal after ISO therapy, B-lymphocyte relative and absolute numbers, however, were not affected by the treatment. Nor were any changes due to ISO found in immunoglobulins, complements, beta 2-micrologbulin and C-reactive protein. Moreover, ISO had no stimulative effect on spotaneous tetrazolium reductase activity of granulocytes but it showed a slight inhibition of their phagocytosis-associated metabolic activity.